Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22210091 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer
Condition: Colorectal Cancer
Intervention: Drug: panitumumab

Indicates status has not been verified in more than two years